How many institutions held COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share in Q1 2026?

9 institutional investors reported COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share for Q1 2026. Use the holders table for investor-level position and value details.

Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP)

Q: What does CUSIP 19188J409 represent in this 13F holders report?

CUSIP 19188J409 is the security identifier for COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 19188J409

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 13,831,528
Total 13F shares: 334,052
Share change: -1,159
Total reported value: $337,392
Price per share: $1.01
Number of holders: 9
Value change: -$1,071
Number of buys: 1
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 19188J409?
CUSIP 19188J409 identifies COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2025

Recent filing periods for CUSIP 19188J409:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of COCP - Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Et al Phillip Frost MD	13D/G 3/4/5	Phillip Frost, M.D. · Director, 10%+ Owner	18%	2,462,012	$3,078,992	+$1,349,571	28 Oct 2025	13D/G 3/4/5
Fred Hassan	3/4/5	Director	— mixed-class rows	2,118,845 mixed-class rows	$2,922,384	—	09 Jan 2026	3/4/5
VANGUARD GROUP INC	13F	Company	1.9%	263,987	$258,444	—	31 Dec 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.91%	126,028	$123,382	—	31 Dec 2025	13F
Richard C. Pfenniger Jr.	3/4/5	Director	— mixed-class rows	87,810 mixed-class rows	$94,867	—	09 Jan 2026	3/4/5
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.6%	82,499	$80,778	—	31 Dec 2025	13F
BlackRock, Inc.	13F	Company	0.53%	73,746	$72,197	—	31 Dec 2025	13F
James Joseph Martin	3/4/5	Co-CEO and CFO	— mixed-class rows	100,592 mixed-class rows	$71,394	—	09 Jan 2026	3/4/5
T3 Companies, LLC	13F	Company	0.38%	52,300	$51,202	—	31 Dec 2025	13F
DRW Securities, LLC	13F	Company	0.24%	33,593	$32,887	—	31 Dec 2025	13F
Neuberger Berman Group LLC	13F	Company	0.23%	31,886	$31,216	—	31 Dec 2025	13F
STATE STREET CORP	13F	Company	0.15%	20,543	$20,112	—	31 Dec 2025	13F
XTX Topco Ltd	13F	Company	0.11%	15,141	$14,823	—	31 Dec 2025	13F
TWO SIGMA SECURITIES, LLC	13F	Company	0.09%	12,752	$12,484	—	31 Dec 2025	13F
Parallel Advisors, LLC	13F	Company	0.09%	12,569	$12,305	—	31 Dec 2025	13F
NORTHERN TRUST CORP	13F	Company	0.09%	11,921	$11,671	—	31 Dec 2025	13F
JANE STREET GROUP, LLC	13F	Company	0.08%	10,626	$10,403	—	31 Dec 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.07%	9,083	$8,892	—	31 Dec 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	0.04%	5,098	$4,991	—	31 Dec 2025	13F
Fortitude Family Office, LLC	13F	Company	0.02%	3,219	$3,151	—	31 Dec 2025	13F
UBS Group AG	13F	Company	0.01%	1,777	$1,740	—	31 Dec 2025	13F
MORGAN STANLEY	13F	Company	0.01%	948	$928	—	31 Dec 2025	13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F	Company	0.01%	817	$800	—	31 Dec 2025	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	788	$772	—	31 Dec 2025	13F
Clean Yield Group	13F	Company	0%	418	$409	—	31 Dec 2025	13F
CITIGROUP INC	13F	Company	0%	390	$382	—	31 Dec 2025	13F
MAI Capital Management	13F	Company	0%	237	$233	—	31 Dec 2025	13F
NVWM, LLC	13F	Company	0%	84	$82	—	31 Dec 2025	13F
SBI Securities Co., Ltd.	13F	Company	0%	33	$32	—	31 Dec 2025	13F
Root Financial Partners, LLC	13F	Company	0%	7	$7	—	31 Dec 2025	13F
Sam Lee	3/4/5	President and Co-CEO	— class O/S missing	49,229	—	—	09 Jan 2026	3/4/5
Roger D. Kornberg	3/4/5	Director	— class O/S missing	24,615	—	—	09 Jan 2026	3/4/5
Anthony J. Japour	3/4/5	Director	— class O/S missing	16,410	—	—	09 Jan 2026	3/4/5
Steven D. Rubin	3/4/5	Director	— class O/S missing	16,410	—	—	09 Jan 2026	3/4/5

Institutional Holders of Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) as of Q1 2026

As of 31 Mar 2026, Cocrystal Pharma, Inc. - Common Stock, par value $0.001 per share (COCP) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 334,052 shares. The largest 9 holders included VANGUARD CAPITAL MANAGEMENT LLC, T3 Companies, LLC, VANGUARD FIDUCIARY TRUST CO, Parallel Advisors, LLC, UBS Group AG, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, Clean Yield Group, NVWM, LLC, and SBI Securities Co., Ltd.. This page lists 9 institutional shareholders reporting positions in this security for the Q1 2026 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

-17

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q1 2026 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.